Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$0.00 – $0.04
100% from low
Exchange
OTC Link
CS
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 1996 | 1997 | 1998 | 1999 | 2000 | 2001 | 2002 | 2003 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $6.3M | $6.2M | $6.2M | $5.7M | $5.9M | $6.0M | $5.9M | $6.0M |
| Cost of revenue | $3.6M | $3.4M | $3.6M | $3.7M | $4.0M | $4.2M | $4.1M | $4.1M |
| Gross profit | $2.7M | $2.8M | $2.6M | $1.9M | $1.9M | $1.9M | $1.7M | $1.9M |
| Gross margin | 42.9% | 45.2% | 41.9% | 34.3% | 32.6% | 30.9% | 29.6% | 31.5% |
| R&D | $100.0K | $200.0K | $200.0K | $184.2K | $71.5K | $3.8K | $107.4K | $116.1K |
| Operating income | $300.0K | $300.0K | $100.0K | $503.9K | $97.6K | $99.5K | $16.5K | $35.1K |
| EBITDA | $500.0K | $500.0K | $300.0K | −$352.8K | $24.1K | $207.3K | $94.8K | $41.4K |
| Net income | $200.0K | $300.0K | $0 | −$297.0K | −$116.9K | $37.8K | $71.2K | $29.0K |
| Net margin | 3.2% | 4.8% | 0.0% | -5.3% | -2.0% | 0.6% | 1.2% | 0.5% |
| EPS (diluted) | 0.09 | 0.12 | 0.02 | -0.15 | -0.06 | 0.02 | 0.03 | 0.01 |
Annual figures · source: Financial Modeling Prep
LANCER ORTHODONTICS INC
No one on the platform currently holds LANZ.
No tracked institution reports a position in LANZ as of their last filing.
No one on the platform has traded LANZ yet.
| $11654 |
| — |
| MSGPMedSmart Group Inc. | $0.00 | +0.00% | $31147 | — |
| ONPHOncology Pharma Inc. | $0.07 | +16.67% | $2M | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.